Product Ascendancy

RECOMBINANT CARBOXYPEPTIDASE B (CPB)
High Specificity
  • The Recombinant protease, precisely cleaves peptide chains mainly at the C-terminus of Lysine and Arginine
  • No any other contaminated proteases, no non-specific cutting sites.
High Specific Activity
  • Specific Activity of the recombinant protease is consistently NLT 180 units/mg thus reducing the amount of the enzyme required for the Biopharmaceutical production.
Animal Origin Free
  • Complete AOF product, thus mitigating the risk of viral and animal component contamination in your final product
REDUNDANCY IN THE PRODUCTION ECONOMICS WITH ESCALATED PROCESS VECTORS
  • Reduce production costs while improving manufacturing processes.
  • No degradation products or impurities, resulting in high enzymatic activity, thus improving process yield.
  • Less downtime and process optimization time required
REDUCE RISK AND STREAMLINE REGULATORY COMPLIANCE
  • Reduce production costs while improving manufacturing processes.
  • Production in accordance to current Good Manufacturing Practice (cGMP) guidelines, reducing risk of contamination.
  • Assurance of reproducible performance and minimal host cell protein contamination.
  • Surge of process safety for high lot-to-lot consistency

Product Ascendancy

Company Sequenc Expression System Specific Activity
D K Biopharma Rat E.coli >NLT 180 U mg
Competitor 1 Rat P.pastoris > NLT 210 U/mg
Competitor 2 Rat E.coli > NLT 170 U/mg
Competitor 3 Rat, Human P.pastoris > NLT 180 U/mg
Competitor 4 Rat E.coli > NLT 100 U/mg

Main Features

Source Recombinant E.coli

Appearance
White or Off-White Powder or Clear
Colorless or lightly Yellowish Liquid
Specific Activity NLT 180 units/mg
Purity (SDS – PAGE) Single Major Band
Molecular Weight 34 kDa
Bioburden NMT 10 CFU/mg